<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03881358</url>
  </required_header>
  <id_info>
    <org_study_id>HSEARS20180322002</org_study_id>
    <nct_id>NCT03881358</nct_id>
  </id_info>
  <brief_title>Orthokeratology for High Myopia (OHM) Study</brief_title>
  <official_title>Orthokeratology for High Myopia (OHM) Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Hong Kong Polytechnic University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Queensland University of Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aston University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Hong Kong Polytechnic University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project aims to investigate/examine high myopic subjects on full correction ortho-k
      (using Topaz ortho-k lenses for high myopia) compared to subjects undergoing partial
      reduction ortho-k and their relationship with myopia and myopic progression.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For many years, commercially-available ortho-k lenses aim to reduce low - moderate myopia.
      Attempts to use these lenses for reduction of high myopia have been shown to give rise to
      complications such as corneal staining and lens decentration. Thus, practitioners may choose
      a more conservative way for high myopic children, that is, offering partial reduction
      ortho-k. Partial reduction ortho-k is target for 4.00-5.00D reduction and the residual
      refractive errors will be corrected with single vision spectacles to allow good visual acuity
      in the daytime. Partial reduction ortho-k has been shown to slow axial elongation in high
      myopic children, however, the main disadvantage is that the children have to wear spectacles
      in the daytime to correct residual refraction.

      Euclid has recently designed a new lens, Euclid's Topaz, for high myopic children. It is
      currently commercially available to correct myopia for up to 10 D. However, evidence of its
      effectiveness for visual correction and slowing AL growth is lacking. While numerous studies
      have shown that orthokeratology is an effective clinical treatment to slow axial eye growth
      in children, the exact mechanism underlying this reduction in myopia progression associated
      with orthokeratology remains unclear.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 4, 2018</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in axial length elongation over 24 months.</measure>
    <time_frame>2 years</time_frame>
    <description>To determine the change in axial length measured at baseline and two years after lens wear using IOLMaster</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>First fit success rate of a newly designed ortho-k lens for high myopic children</measure>
    <time_frame>1 month</time_frame>
    <description>The success rate in using the first pair of lenses to achieve target refractive correction will be determined</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life (questionnaire)</measure>
    <time_frame>3 months</time_frame>
    <description>Quality of life will be determined by questionnaires (using revised Pediatric Refractive Error Profile (PREP) 1 in traditional Chinese version) before and after ortho-k in the two groups of subjects</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ocular aberration</measure>
    <time_frame>2 years</time_frame>
    <description>Ocular aberration will be measured by Complete Ophthalmic Analysis System (COAS) aberrometer</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Myopia</condition>
  <condition>High Myopia</condition>
  <arm_group>
    <arm_group_label>ortho-k lenses and thinner spectacles</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>participants using conventionally designed ortho-k lenses (target for 4.00D) and thinner spectacles during day time</description>
  </arm_group>
  <arm_group>
    <arm_group_label>newly designed ortho-k lenses</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>participants using newly designed ortho-k lenses for high myopia (target for full correction)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ortho-k lenses and thinner spectacles</intervention_name>
    <description>Conventinally designed (Emerald) ortho-k lenses (target for -4.00D) and thinner specs during day time</description>
    <arm_group_label>ortho-k lenses and thinner spectacles</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>newly designed ortho-k lenses</intervention_name>
    <description>Newly designed (Topaz) ortho-k lenses for high myopia (target for full correction)</description>
    <arm_group_label>newly designed ortho-k lenses</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Myopia: at least 5.00D in one eye or in both eyes

          -  Astigmatism: ≤1.50D; with-the-rule astigmatism (axes 180 ± 30) ≤1.25D; astigmatism of
             other axes ≤0.50D in both eyes

          -  Anisometropia: not be more than 1.00D in the former and not more than 2.00D in the
             latter.

          -  Best-corrected Monocular Snellen visual acuity 6/7.5 or better

        Exclusion Criteria:

          -  Strabismus at distance or near

          -  Previous experience in contact lens wear or myopia control treatment (e.g. refractive
             therapy or progressive spectacles)

          -  Contraindication for contact lens wear and orthokeratology (e.g. limbus to limbus
             corneal cylinder and dislocated corneal apex)

          -  Previous history of ocular surgery, trauma, or chronic ocular disease

          -  Concurrent use of medications that may affect tear quality or contact lens wear

          -  Systemic or ocular conditions that may affect tear quality or contact lens wear (e.g
             allergy and concurrent medication) or that may affect refractive development (e.g Down
             syndrome, ptosis)

          -  Poor compliance to tests (e.g poor fixation in noncontact tonometry or intolerance of
             lens wear)

          -  Not willing to comply with the allocated treatment, use and care of lenses and
             follow-up schedule
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>13 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pauline Cho, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hong Kong Polytechnic University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pauline Cho, PhD</last_name>
    <phone>(+852) 2766 6100</phone>
    <email>pauline.cho@polyu.edu.hk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yajing Yang, BSc</last_name>
    <phone>(+852) 6486 2435</phone>
    <email>grace.yj.yang@connect.polyu.hk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>School of Optometry, The Hong Kong Polytechnic University</name>
      <address>
        <city>Kowloon</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pauline Cho, PhD</last_name>
      <phone>(+852)2766 6100</phone>
      <email>pauline.cho@polyu.edu.hk</email>
    </contact>
    <contact_backup>
      <last_name>Yajing Yang, BSc</last_name>
      <phone>(+852)6486 2435</phone>
      <email>grace.yj.yang@connect.polyu.hk</email>
    </contact_backup>
    <investigator>
      <last_name>Pauline Cho, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <reference>
    <citation>Lam CS, Goldschmidt E, Edwards MH. Prevalence of myopia in local and international schools in Hong Kong. Optom Vis Sci. 2004 May;81(5):317-22.</citation>
    <PMID>15181356</PMID>
  </reference>
  <reference>
    <citation>Walline JJ, Lindsley K, Vedula SS, Cotter SA, Mutti DO, Twelker JD. Interventions to slow progression of myopia in children. Cochrane Database Syst Rev. 2011 Dec 7;(12):CD004916. doi: 10.1002/14651858.CD004916.pub3. Review. Update in: Cochrane Database Syst Rev. 2020 Jan 13;1:CD004916.</citation>
    <PMID>22161388</PMID>
  </reference>
  <reference>
    <citation>Kakita T, Hiraoka T, Oshika T. Influence of overnight orthokeratology on axial elongation in childhood myopia. Invest Ophthalmol Vis Sci. 2011 Apr 6;52(5):2170-4. doi: 10.1167/iovs.10-5485.</citation>
    <PMID>21212181</PMID>
  </reference>
  <reference>
    <citation>Cho P, Cheung SW, Edwards M. The longitudinal orthokeratology research in children (LORIC) in Hong Kong: a pilot study on refractive changes and myopic control. Curr Eye Res. 2005 Jan;30(1):71-80.</citation>
    <PMID>15875367</PMID>
  </reference>
  <reference>
    <citation>Swarbrick HA. Orthokeratology review and update. Clin Exp Optom. 2006 May;89(3):124-43. Review.</citation>
    <PMID>16637967</PMID>
  </reference>
  <reference>
    <citation>Walline JJ, Jones LA, Sinnott LT. Corneal reshaping and myopia progression. Br J Ophthalmol. 2009 Sep;93(9):1181-5. doi: 10.1136/bjo.2008.151365. Epub 2009 May 4.</citation>
    <PMID>19416935</PMID>
  </reference>
  <reference>
    <citation>Charm J, Cho P. High myopia-partial reduction orthokeratology (HM-PRO): study design. Cont Lens Anterior Eye. 2013 Aug;36(4):164-70. doi: 10.1016/j.clae.2013.02.012. Epub 2013 Mar 18.</citation>
    <PMID>23518209</PMID>
  </reference>
  <reference>
    <citation>Cho P, Cheung SW, Edwards MH. Practice of orthokeratology by a group of contact lens practitioners in Hong Kong. Part 2: orthokeratology lenses. Clin Exp Optom. 2003 Jan;86(1):42-6.</citation>
    <PMID>12568650</PMID>
  </reference>
  <reference>
    <citation>Lee TT, Cho P. Relative peripheral refraction in children: twelve-month changes in eyes with different ametropias. Ophthalmic Physiol Opt. 2013 May;33(3):283-93. doi: 10.1111/opo.12057.</citation>
    <PMID>23662961</PMID>
  </reference>
  <reference>
    <citation>Atchison DA, Li SM, Li H, Li SY, Liu LR, Kang MT, Meng B, Sun YY, Zhan SY, Mitchell P, Wang N. Relative Peripheral Hyperopia Does Not Predict Development and Progression of Myopia in Children. Invest Ophthalmol Vis Sci. 2015 Sep 1;56(10):6162-70. doi: 10.1167/iovs.15-17200.</citation>
    <PMID>26397463</PMID>
  </reference>
  <reference>
    <citation>Hiraoka T, Matsumoto Y, Okamoto F, Yamaguchi T, Hirohara Y, Mihashi T, Oshika T. Corneal higher-order aberrations induced by overnight orthokeratology. Am J Ophthalmol. 2005 Mar;139(3):429-36.</citation>
    <PMID>15767050</PMID>
  </reference>
  <reference>
    <citation>González-Méijome JM, Villa-Collar C, Queirós A, Jorge J, Parafita MA. Pilot study on the influence of corneal biomechanical properties over the short term in response to corneal refractive therapy for myopia. Cornea. 2008 May;27(4):421-6. doi: 10.1097/ICO.0b013e318164e49d.</citation>
    <PMID>18434845</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 21, 2019</study_first_submitted>
  <study_first_submitted_qc>March 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 19, 2019</study_first_posted>
  <last_update_submitted>March 3, 2020</last_update_submitted>
  <last_update_submitted_qc>March 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Hong Kong Polytechnic University</investigator_affiliation>
    <investigator_full_name>Pauline Cho</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Myopia control</keyword>
  <keyword>Orthokeratology</keyword>
  <keyword>Children</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

